RhumbLine Advisers’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.45M | Buy |
210,001
+21,477
| +11% | +$250K | ﹤0.01% | 1779 |
|
|
2025
Q1 | $1.4M | Buy |
188,524
+7,322
| +4% | +$54.4K | ﹤0.01% | 2005 |
|
|
2024
Q4 | $1.09M | Buy |
181,202
+5,361
| +3% | +$32.1K | ﹤0.01% | 2214 |
|
|
2024
Q3 | $900K | Sell |
175,841
-12,444
| -7% | -$63.7K | ﹤0.01% | 2317 |
|
|
2024
Q2 | $682K | Buy |
188,285
+14,430
| +8% | +$52.2K | ﹤0.01% | 2452 |
|
|
2024
Q1 | $558K | Buy |
173,855
+4,290
| +3% | +$13.8K | ﹤0.01% | 2604 |
|
|
2023
Q4 | $831K | Buy |
169,565
+9,346
| +6% | +$45.8K | ﹤0.01% | 2366 |
|
|
2023
Q3 | $873K | Buy |
160,219
+2,969
| +2% | +$16.2K | ﹤0.01% | 2286 |
|
|
2023
Q2 | $1.06M | Sell |
157,250
-20,947
| -12% | -$141K | ﹤0.01% | 2255 |
|
|
2023
Q1 | $1.57M | Buy |
178,197
+6,183
| +4% | +$54.6K | ﹤0.01% | 1930 |
|
|
2022
Q4 | $1.31M | Buy |
172,014
+1,550
| +0.9% | +$11.8K | ﹤0.01% | 2005 |
|
|
2022
Q3 | $1.21M | Buy |
170,464
+10,091
| +6% | +$71.9K | ﹤0.01% | 2036 |
|
|
2022
Q2 | $1.3M | Buy |
160,373
+64,121
| +67% | +$519K | ﹤0.01% | 2008 |
|
|
2022
Q1 | $1.34M | Sell |
96,252
-6,976
| -7% | -$96.8K | ﹤0.01% | 2007 |
|
|
2021
Q4 | $2.9M | Buy |
103,228
+4,739
| +5% | +$133K | ﹤0.01% | 1694 |
|
|
2021
Q3 | $3.35M | Sell |
98,489
-1,329
| -1% | -$45.2K | ﹤0.01% | 1596 |
|
|
2021
Q2 | $4.08M | Buy |
99,818
+23,136
| +30% | +$945K | 0.01% | 1530 |
|
|
2021
Q1 | $3.09M | Sell |
76,682
-9,246
| -11% | -$372K | ﹤0.01% | 1677 |
|
|
2020
Q4 | $5.08M | Buy |
85,928
+1,928
| +2% | +$114K | 0.01% | 1348 |
|
|
2020
Q3 | $4.09M | Buy |
84,000
+3,775
| +5% | +$184K | 0.01% | 1289 |
|
|
2020
Q2 | $3.88M | Buy |
80,225
+20,179
| +34% | +$976K | 0.01% | 1354 |
|
|
2020
Q1 | $1.67M | Buy |
60,046
+44,386
| +283% | +$1.23M | ﹤0.01% | 1639 |
|
|
2019
Q4 | $469K | Buy |
15,660
+4,291
| +38% | +$129K | ﹤0.01% | 2389 |
|
|
2019
Q3 | $351K | Buy |
+11,369
| New | +$351K | ﹤0.01% | 2493 |
|